ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,751,620 | -11.7% | 433,000 | 0.0% | 11.84% | -18.2% |
| Q2 2023 | $13,310,420 | -14.7% | 433,000 | 0.0% | 14.48% | -20.5% |
| Q1 2023 | $15,600,990 | -14.6% | 433,000 | -6.3% | 18.22% | -8.9% |
| Q4 2022 | $18,258,240 | -12.9% | 462,000 | -11.5% | 20.01% | -6.9% |
| Q3 2022 | $20,964,000 | -12.8% | 521,750 | -8.7% | 21.48% | +1.3% |
| Q2 2022 | $24,030,000 | -18.5% | 571,588 | -24.5% | 21.21% | -4.2% |
| Q1 2022 | $29,488,000 | -8.2% | 756,874 | -6.1% | 22.15% | -5.0% |
| Q4 2021 | $32,118,000 | +26.7% | 805,982 | +14.9% | 23.31% | +13.6% |
| Q3 2021 | $25,346,000 | -13.1% | 701,323 | -1.4% | 20.53% | -13.2% |
| Q2 2021 | $29,169,000 | +4073.0% | 711,623 | +4341.3% | 23.64% | +2870.4% |
| Q1 2021 | $699,000 | -29.2% | 16,023 | -18.7% | 0.80% | -30.7% |
| Q4 2020 | $987,000 | +0.7% | 19,718 | -15.3% | 1.15% | -6.4% |
| Q3 2020 | $980,000 | +129.5% | 23,288 | +149.7% | 1.23% | +129.1% |
| Q2 2020 | $427,000 | – | 9,328 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |